In line with this, it was shown that down-regulation of E-cadherin might be a marker suitable for the prediction of metastasis in pancreatic cancer, albeit only in combination with up-regulation of urokinase-type plasminogen activator (uPA) [110]. The gene discussed is CDH1; the disease is pancreatic neoplasm.